Fluoride exposure linked to ‘detrimental effects' on health of pregnant women, infants
Fluoride has long been used as a dental health tool as a means of preventing cavities and fighting tooth decay — but now a new meta-analysis suggests it could have "detrimental effects" on the health of pregnant women and infants.
Researchers analyzed various studies, concluding that exposure to fluoride "offers little benefit to the fetus and young infant."
Systemic fluoride exposure can have a harmful impact on bone strength, thyroid function and cognitive development, according to the findings, which were published in the Annual Review of Public Health.
"Community-wide administration of systemic fluoride may pose an unfavorable risk–benefit ratio for the pregnant woman, fetus and infant," reads the meta-analysis.
Philippe Grandjean, a researcher on the study and professor of environmental medicine at the University of Southern Denmark, told Fox News Digital that "fluoride is toxic to early brain development."
"It is not dependent on the source of the fluoride," Grandjean. "In addition to fluoridated drinking water, we need to limit ingestion of fluoridated toothpaste, which by itself is great for dental health, but don't swallow it."
He recommended avoiding consumption of certain kinds of black tea – "especially those that are grown in fluoride-rich soils (e.g., East Africa and certain parts of China and India)."
The Centers for Disease Control and Prevention (CDC) states that fluoride strengthens teeth and reduces cavities by replacing minerals lost during normal wear and tear.
The review noted that with growing access to fluoride over the years, fluoride's beneficial effect is predominantly topical, citing that there is no need for widespread community fluoridation.
During an appearance last week on "The Story With Martha MacCallum." HHS Secretary Robert F. Kennedy Jr. said that "exposure to fluoride is dose-related."
"In other words, the more fluoride you get, the lower your IQ is going to be … the benefits of fluoride are topical," Kennedy added.
"It was originally thought that when we put it in the water back in the 1940s that they were systemic," he went on. "In other words, if you drank it, it would do something to your body to prevent growth of cavities. But that's not how it works."
The HHS secretary added that fluoride is associated with "with extreme losses in bone density."
More than 200 million Americans, or about 75% of the population, currently drink fluoridated water.
"The entire benefit of it comes from topical application ... there's really no reason to have it in the water supply in this era where we have toothpaste and mouthwashes," Kennedy concluded.
Kennedy said he plans to tell the CDC to stop recommending the addition of fluoride to drinking water, the Associated Press reported.
Utah recently became the first state to pass legislation banning fluoride in public drinking water.
Governor Spencer Cox signed the bill into law last month, a move that was applauded by those supporting the "Make America Healthy Again" movement.
For more Health articles, visit www.foxnews.com/health
Lawmakers in other states, including Ohio, South Carolina and Florida, have also submitted proposals to restrict local governments or water system operators from adding fluoride to water.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
35 minutes ago
- USA Today
See which U.S. cities report 'forever chemicals' in drinking water
See which U.S. cities report 'forever chemicals' in drinking water Water pouring from the faucets of at least 42 million Americans is contaminated with unacceptable levels of 'forever chemicals,' according to a USA TODAY analysis of records the Environmental Protection Agency released on June 2. Per- and polyfluoroalkyl substances, or PFAS, are a family of manmade chemicals engineered to be nearly indestructible. Studies have shown they can accumulate over time in human bodies, leading to certain cancers and other health complications. Over the past two years, the EPA has collected complete sets of test results from about 6,900 drinking water systems, with thousands more expected as the PFAS testing initiative continues another year. USA TODAY's analysis of these systems with complete results shows nearly a quarter of large water utilities serving at least 100,000 customers exceeded limits the EPA approved last year on two chemicals: PFOS and PFOA. Water systems in Fairfax County, Virginia, and San Juan, Puerto Rico – each serving over 1 million customers – have now joined the list of utilities with test results that averaged over the limits in the EPA's latest data. USA TODAY's analysis also shows that Tempe, Arizona, which provides water to over 165,000 people, has joined that list. Multiple test locations there failed to meet the EPA standards. PFOS at one sample site averaged 55 parts per trillion (ppt), several times higher than the acceptable limit of 4 ppt. Altogether, USA TODAY found 774 systems don't meet the limits for forever chemicals. These utilities will likely need to install advanced filtration systems or find alternative sources of drinking water by 2031. The deadline for systems to meet the water standards was originally set for 2029, but in May, the EPA proposed an extension and announced it intends to rescind limits on four other types of PFAS set under the Biden administration in 2024. EPA Administrator Lee Zeldin said the delay was to provide 'common-sense flexibility' to 'support water systems across the country, including small systems in rural communities, as they work to address these contaminants.' Industry groups representing water utilities have sued the EPA, alleging the agency did not follow the proper procedures when approving PFAS limits last year. Last month, Zeldin said rescinding the limits on the other four forever chemicals would ensure they 'follow the legal process laid out in the Safe Drinking Water Act.' The lawsuit has been on hold since February to allow time for the new administration to review the issues. On June 4, the hold was extended through July 21 'while the United States determines the most appropriate course of action for this litigation in light of EPA's decision to reconsider portions of the challenged rule.' Advocacy organizations have denounced the EPA's proposed changes on forever chemicals. Melanie Benesh, vice president of government affairs for the Environmental Working Group, described the move as a 'public health betrayal.' 'Communities have waited decades for protection – now the EPA is pulling the rug out,' Benesh said. 'Science is clear: PFAS are dangerous even in tiny amounts. The agency must protect all Americans, not just from two chemicals, but from the entire class of harmful PFAS.'
Newsweek
an hour ago
- Newsweek
Why Are So Many Children Getting Long COVID?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. It's been more than five years since the start of the COVID-19 pandemic, although millions of Americans, including children, are still affected by it today. More than one million Americans died due to the virus, according to the Centers for Disease Control and Prevention (CDC), while many were floored by the infection for weeks or even months. Others developed long COVID, which is recognized as a collection of symptoms that last three months or longer after initial COVID symptoms appear. This can affect many systems in the body and result in a wide range of health complications and symptoms. File photo: a mother holds her daughter while she has a COVID-19 test done in a clinic in Washington. File photo: a mother holds her daughter while she has a COVID-19 test done in a clinic in Washington. Carolyn Kaster/AP A study by Researching COVID to Enhance Recovery (RECOVER) last year found that up to 5.8 million American children now have long COVID. The authors wrote that this means between 10 to 20 percent of children who tested positive with COVID-19 went on to develop the condition. Their findings suggest that long COVID may have surpassed asthma—which around 5 million youngsters have—as the most common chronic condition experienced by American children. However, experts told Newsweek that more detailed research is needed to determine the prevalence of the condition, and discussed why millions of children now have ongoing health complications and symptoms post-COVID infection. Prevalence of Long COVID in Children Children of all ages can develop long COVID and typical symptoms can vary between age groups. Poor appetite, sleep issues and respiratory symptoms such as a cough are usually common in infants, toddlers and preschool-aged children with the condition, while school-aged children are also likely to have neurological symptoms like trouble focusing, fear of specific things or feeling lightheaded, the medical journal site JAMA Network reported. Some children may also experience back or neck pain, headache, stomach pain, vomiting and even behavioral changes. Adolescents may also notice a change or loss in smell or taste and experience pain, fatigue-related symptoms or trouble with their memory, JAMA Network said. It is difficult to pin down exactly how common long COVID really is among those aged under 18 as "prevalence varies between studies due to different clinical definitions, follow-up period and survey methods used," Dr. Akiko Iwasaki, director of the Center for Infection and Immunity at the Yale School of Medicine, told Newsweek. However, she added that "the most robust studies" collectively suggest the number of children who get infected with COVID and then develop long COVID "is higher than the prevalence of asthma in children in the U.S." Also discussing the study, Dr. Lauren Grossman, a professor of medicine at Stanford University, told Newsweek: "The number of children under 18 with asthma ranges from 4.9 million to 6 million depending on the source so it's not an incorrect statement to say that there are more or at least the same number of children with asthma as there are with long COVID." Many children are also going "unrecognized and unsupported," Dr. Rachel Gross, a professor in the department of pediatrics at NYU Langone Health, told Newsweek. She added that this means "identifying long COVID in children, especially young children, can be difficult due to rapid developmental changes and communication limitations." However, Dr. Gerald Teague, a professor of pediatrics at the University of Virginia School of Medicine, said that "there are too few prospective studies to compare estimates of long COVID to asthma in children." "We need to come to consensus on how to precisely diagnose long COVID in children first," he told Newsweek, adding that the National Institutes of Health (NIH) and the federal government should "allocate more funding to antiviral research in children to help clear these confusing issues." Gross also said that the age differences in long COVID symptoms "support that a one-size fits all approach will likely not be sufficient to screen for, identify, and treat children with long COVID." Why Do So Many Children Have Long COVID? One reason long COVID continues to affect millions of American children could be related to vaccinations, according to Grossman. "As vaccinations help prevent long COVID and vaccinations were not available to pediatric patients until long after they were for adults, fewer children had protection," she said. She added that the first vaccines were given to adults in December 2020, while children aged 5 to 11 only received their first vaccination in October 2021. Teague also said that studies have found that the original COVID strain in 2020 was far more likely to result in patients developing long COVID, while more recent strains were "not as likely to be associated with symptoms." Few children being vaccinated amid the first, more symptom-inducing strain of the virus may therefore have contributed to the higher rates of long COVID. Child COVID vaccinations have also recently come into the spotlight as Health Secretary Robert F. Kennedy Jr., who has been vocal in his distrust of the mRNA COVID vaccine, announced last month that the CDC will no longer recommend COVID vaccines for "healthy children and healthy pregnant women." Grossman added that Paxlovid, the antiviral medication used to treat COVID infection, was first authorized in December 2021, but only for those aged 12 and over, or those who weighed more than 88 lbs., meaning younger children did not have access to medication. It is important to note, however, that "the prevalence for long COVID in children appears to be just as high in adults," Iwasaki said. "This suggests that children are not immune to developing long COVID, and that their immune system is also susceptible to being derailed by the virus," she added. Iwasaki said that this could mean that COVID infection "might become persistent or trigger autoimmune diseases in children," and that there could be "other viral infections that happen during childhood that impact long COVID susceptibility." However, she said that more research is needed to better understand the underlying mechanisms of long COVID in youngsters. "We need more awareness so that parents and pediatricians can recognize the signs of long COVID in children better," Iwasaki said. "The relationship between children, their caregivers, and pediatricians is vital to identify and eventually treat this under-recognized condition," Gross said. Grossman said that establishing pediatric-specializing long COVID clinics was vital as currently there are "very few," and that promoting "full vaccination" was also important. While more robust studies are beginning to be done on the issue, it is still difficult to determine the overall impact and severity of long COVID on America's children.
Medscape
3 hours ago
- Medscape
CVD Mortality Higher in Women With Inflammatory Diseases
Although cardiovascular disease (CVD)-related mortality decreased significantly from 1999 to 2020 in both men and women with immune-mediated inflammatory diseases (IMIDs), women consistently had higher rates of CVD-related mortality than men over the 22-year period. METHODOLOGY: Researchers analyzed CDC Multiple Cause of Death files from 1999 to 2020 to assess the sex differences in CVD-related mortality in patients with IMIDs. They identified CVD-related deaths with underlying IMIDs in the United States using diagnostic codes. IMIDs such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis were analyzed. The analysis included 281,355 IMID-related deaths and 127,149 CVD-related deaths over a period of 22 years. Annual crude and adjusted death rates were estimated. TAKEAWAY: Age-adjusted CVD-related mortality for women with IMIDs declined from 3.3 per 100,000 in 1999 to 1.4 per 100,000 in 2020, whereas the rate in men with IMIDs declined from 2.3 to 1.1 per 100,000 ( P < .01). < .01). However, women had higher mortality than men throughout the study duration (mortality rate ratio, 1.5; P < .01). < .01). Cerebrovascular disease and ischemic heart disease were major causes of death, with women more affected than men; women experienced mortality from arrhythmia and cardiac arrest at more than twice the rate of men. Among patients with IMIDs, women with rheumatoid arthritis had disproportionately higher crude CVD-related mortality than men with rheumatoid arthritis. IN PRACTICE: 'Addressing these risks requires increasing awareness of atypical cardiovascular symptoms in females with IMIDs, enhancing early detection through advanced imaging, and ensuring equitable access to therapies like biologics,' the study authors wrote. SOURCE: This study was led by Issam Motairek, MD, Cleveland Clinic, Cleveland. It was published online on May 5, 2025, in Circulation: Cardiovascular Quality and Outcomes . LIMITATIONS: The potential inaccuracies in the codes for identifying the cause of death may have misclassified IMIDs or CVD-related causes. The aggregate data structure prevented the analyses of individual-level factors such as severity of disease or treatments. Less common IMIDs were excluded, which may have underestimated their contribution to CVD. DISCLOSURES: This study received no specific funding. The authors reported having no conflicts of interest.
